Dr. Reddy's Laboratories

Indian multinational pharmaceutical company

Dr. Reddy's Laboratories ▸ Facts ▸ Comments ▸ News ▸ Videos

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

0 shares	Share Tweet Save Post Send



Covid update: N95 mask export allowed; India ranks 4th; festival guidelines From the Union government lifting restrictions on the export of N-95/FFP2 face masks, to India ranking fourth in a survey of public perception regarding response to the pandemic - here are the top news.. Credit: HT Digital Content Duration: 03:14Published 3 weeks ago

Opening Bell: Equity indices in the red amid weak global cues Equity benchmark indices were down on September 30. At 10:00 am, the BSE was down by 95 points or 0.25 per cent and was trading at 37,876, while Nifty was trading also dipped by 7 points or -0.06 per.. Credit: ANI Duration: 01:10Published on September 30, 2020

Equity indices trade higher, pharma stocks rally Equity benchmark indices traded higher during early hours on Friday amid mixed cues from their Asian peers. At 10:15 am, the BSE S-P Sensex was up by 136 points or 0.35 per cent at 39,115 while the.. Credit: ANI Duration: 01:24Published on September 18, 2020

Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer Equity benchmark indices traded higher in the afternoon session on September 16 while Asian stocks were flat ahead of the US Federal Reserve's view on the economy. The BSE S-P Sensex closed 259 points.. Credit: ANI Duration: 01:21Published on September 16, 2020

You Might Like

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on.. IndiaTimes - Published 3 days ago
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company.. IndiaTimes - Published 1 week ago
India declines proposal to test Sputnik-V Covid-19 vaccine in large study India's drug regulator has knocked back a proposal from Dr Reddy's Laboratories Ltd to conduct a large study in the country to evaluate Russia's Sputnik-V Covid-19 vaccine and has asked it to first.. IndiaTimes - Published 3 weeks ago

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: Dr Reddy's Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the Indian drugmaker said on Tuesday. IndiaTimes - Published on September 22, 2020
COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds.. DNA - Published on September 17, 2020
Russia, Dr Reddy’s tie up for Sputnik V trial Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of.. IndiaTimes - Published on September 16, 2020

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds up plans to.. DNA - Published on September 16, 2020
Russia to sell 100 million doses of Covid-19 vaccine to India Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval... IndiaTimes - Published on September 16, 2020

Dr. Reddy's Laboratories

Indian multinational pharmaceutical company

Dr. Reddy's Laboratories ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

India declines proposal to test Sputnik-V Covid-19 vaccine in large study

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: Dr Reddy's

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses

Russia to sell 100 million doses of Covid-19 vaccine to India